UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.

Johnson, M; Wagstaffe, HR; Gilmour, KC; Mai, AL; Lewis, J; Hunt, A; Sirr, J; ... Goldblatt, D; + view all (2020) Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2. Journal of Clinical Virology , 130 , Article 104572. 10.1016/j.jcv.2020.104572. Green open access

[thumbnail of 1-s2.0-S1386653220303140-main.pdf]
Preview
Text
1-s2.0-S1386653220303140-main.pdf - Published Version

Download (1MB) | Preview

Abstract

BACKGROUND: The emergence of SARS-CoV-2 has led to the development of serological assays that could aid in an understanding of the burden of COVID-19 disease. Many available tests lack rigorous evaluation and therefore results may be misleading. OBJECTIVES: The aim of this study was to assess the performance of a novel multiplexed immunoassay for the simultaneous detection of antibodies against SARS-CoV-2 trimeric spike (S), spike receptor binding domain (RBD), spike N terminal domain and nucleocapsid antigen and a novel pseudo-neutralisation assay. METHODS: A multiplexed solid-phase chemiluminescence assay (Meso Scale Discovery) was evaluated for the simultaneous detection of IgG binding to four SARS-CoV-2 antigens and the quantification of antibody-induced ACE-2 binding inhibition (pseudo-neutralisation assay). Sensitivity was evaluated with a total of 196 COVID-19 serum samples (169 confirmed PCR positive and 27 anti-nucleocapsid IgG positive) from individuals with mild symptomatic or asymptomatic disease. Specificity was evaluated with 194 control serum samples collected from adults prior to December 2019. RESULTS: The specificity and sensitivity of the binding IgG assay was highest for S protein with a specificity of 97.4 % and sensitivity of 96.2 % for samples taken 14 days and 97.9 % for samples taken 21 days following the onset of symptoms. IgG concentration to S and RBD correlated strongly with percentage inhibition measured by the pseudo-neutralisation assay. CONCLUSION: Excellent sensitivity for IgG detection was obtained over 14 days since onset of symptoms for three SARS-CoV-2 antigens (S, RBD and N) in this multiplexed assay which can also measure antibody functionality.

Type: Article
Title: Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2.
Location: Netherlands
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.jcv.2020.104572
Publisher version: https://doi.org/10.1016/j.jcv.2020.104572
Language: English
Additional information: © 2020 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/BY-NC-ND/4.0/).
Keywords: Covid19, Immunoassays, Immunology, SARS-CoV-2
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Population, Policy and Practice Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10107705
Downloads since deposit
114Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item